Option Care Health is looking to deepen its payer partnerships as stakeholders across the health care spectrum look for opportunities to “right size care,” said CEO John Rademacher.

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected ...

Alternate site health provider Option Care Health (NASDAQ:OPCH) will be reporting results this Tuesday before the bell. Here’s what you need to know. Option Care Health beat analysts’ revenue ...

Management projected full-year 2025 revenue of $5.6 billion to $5.65 billion, adjusted EBITDA of $468 million to $473 million, and adjusted EPS of $1.68 to $1.72. Sethna said, "We continue to expect ...

Management expects meaningful pressure from STELARA biosimilar conversions — a ~160-basis-point revenue drag in 2025 and an anticipated ~400-basis-point revenue growth headwind plus a $25–35 million ...

After market close Monday, Option Care Health unveiled those preliminary and unaudited figures. For its fourth quarter of 2025, the company anticipates booking $1.46 billion to $1.47 billion in net ...

Previous title: Executive vice president and chief financial officer, Littelfuse New title: Executive vice president and chief financial officer, Option Care Health Sethna will assume the head finance ...

Jefferies has upgraded Option Care Health (NASDAQ:OPCH) to buy from hold, citing removal of an overhang related to pricing adjustments for the drug Stelara. The investment bank said it had downgraded ...

Option Care Health (NASDAQ:OPCH) will release its quarterly earnings report on Tuesday, 2026-02-24. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Option Care ...

Option Care Enterprises, Inc., one of the nation’s leading providers of home and alternate treatment site infusion therapy services, has earned URAC Specialty Pharmacy accreditation with a perfect ...